Activity
The company is dedicated to the development, co-development, manufacturing, and supply of clinical batches of pharmaceutical products, specializing in cytotoxic and high-potency products, particularly in the oncology field. It offers a comprehensive range of pharmaceutical services, spanning from research to commercialization.
History
The company has more than 80 years of history in the pharmaceutical sector, establishing itself as a benchmark in the production of high-potency and cytotoxic pharmaceutical specialties.
Product types
It offers pharmaceutical products such as oral cytostatic formulations (hard capsules, sachets, film-coated tablets, and sugar-coated tablets), non-cytostatic parenteral formulations (vials, ampoules, prefilled syringes), and cytostatic parenteral formulations (liquids, lyophilized formulations). It also provides services such as development, co-development, regulatory affairs, clinical research, production, logistics, marketing, and licensing agreements.
Mission
The company's mission is to offer quality and consistent pharmaceutical products and services, promoting excellence, flexibility, innovation, and professional growth, with a strong social and environmental commitment focused on sustainability and the continuous improvement of health and quality of life.
